Sequence alterations in RX in patients with microphthalmia, anophthalmia, and coloboma

Nikolas J S London, Patricia M Kessler, Bryan Raymond George Williams, Gayle J Pauer, Stephanie A Hagstrom, Elias I Traboulsi

Research output: Contribution to journalArticleResearchpeer-review

24 Citations (Scopus)

Abstract

PURPOSE: Microphthalmia, anophthalmia, and coloboma are ocular malformations with a significant genetic component. Rx is a homeobox gene expressed early in the developing retina and is important in retinal cell fate specification as well as stem cell proliferation. We screened a group of 24 patients with microphthalmia, coloboma, and/or anophthalmia for RX mutations. METHODS: We used standard PCR and automated sequencing techniques to amplify and sequence each of the three RX exons. Patients charts were reviewed for clinical information. The pathologic impact of the identified sequence variant was analyzed by computational methods using PolyPhen and PMut algorithms. RESULTS: In addition to the polymorphisms we identified a single patient with coloboma having a heterozygous nucleotide change (g.197G>C) in the first exon that results in a missense mutation of arginine to threonine at amino acid position 66 (R66T). In silico analysis predicted R66T to be a deleterious mutation. CONCLUSIONS: Sequence variations in RX are uncommon in patients with congenital ocular malformations, but may play a role in disease pathogenesis. We observed a missense mutation in RX in a patient with a small, typical chorioretinal coloboma, and postulate that the mutation is responsible for the patient s phenotype.
Original languageEnglish
Pages (from-to)162 - 167
Number of pages6
JournalMolecular Vision
Volume15
Publication statusPublished - 2009

Cite this